Our data, together with previous reports showing that DYRK2 controls proteasome activity [34], presents DYRK2 as a major apical positive regulator of two main pathways involved in alleviation of proteotoxic stress in cancer cells, and thus two main mechanisms by which aneuploid cells adapt, survive and become malignant. Here, DYRK2 is linked to cancer.